Police Minister Bheki Cele. The portfolio committee on police is considering amending the IPID Act to bring municipal law enforcement agencies into its ambit.This, after a heated committee meeting where Police Minister Bheki Cele and the DA differed over whether there was oversight over the City of Cape Town's law enforcement unit.This forms part of…
Limpopo MEC for Health Dr Phophi Ramathuba (Gallo Images / Sowetan / Sandile Ndlovu, file) The committee says it received numerous concerns warning of serious allegations of malfeasance and corruption in Covid-19 related procurement.It also noted that in less than two months, the province's health department had gone from spending a quarter of a billion,…
Police Minister Bheki Cele. The Portfolio Committee on Police approved Dikaledi Jennifer Ntlaseng's appointment as the new Executive Director of the Independent Police Investigative Directorate.The DA and FF Plus have objected to the appointment.The committee obtained a legal opinion that they could continue with the process, despite a pending court case by the Helen Suzman…
Minister of Communications Stella Ndabeni-Abrahams. Lisa Hnatowicz, Gallo Images, Foto24 Opposition MPs slammed Communications Minister Stella Ndabeni-Abrahams for attempting to supersede the National Assembly's powers in the appointment of the Icasa council.The Portfolio Committee on Communications obtained a legal opinion that what the minister proposed was unlawful. The committee agreed not to accede to Ndabeni-Abrahams' request…
Tina Joemat-Pettersson. (Netwerk24) President Cyril Ramaphosa enacted the Independent Police Investigative Directorate Amendment Bill.This bill removes the power to fire IPID's head from the Minister of Police, and gives it to the Portfolio Committee on Police.This amendment was required by a Constitutional Court ruling. The independence of the Independent Police Investigative Directorate (IPID) has been strengthened after…
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.
You don't have permission to access "http://www.medpagetoday.com/washington-watch/washington-watch/123652" on this server. Reference #18.d494d817.1793332899.22e6a54f https://errors.edgesuite.net/18.d494d817.1793332899.22e6a54f